Shuttle Pharma Pivots to Dogecoin Mining

Nasdaq-listed pharmaceutical giant Shuttle Pharma just announced a bold pivot into crypto mining, targeting Dogecoin (DOGE) in what stands as the first significant institutional play for meme coin extraction. This move shakes up the sector, blending traditional pharma expertise with blockchain's high-stakes game, especially as Bitcoin (BTC) hype fuels broader crypto adoption over the past six months. Investors eye this as a signal for more cross-industry shifts, potentially boosting Dogecoin mining pivot strategies and institutional crypto play momentum.

From a technical confluence standpoint, DOGE trades at $0.11 on the 4-hour chart, riding a bullish trend with the EMA50 and EMA200 both anchoring support at $0.1. MACD flashes a golden cross at 0.0, confirming upward momentum, while RSI sits neutral at 62.81, avoiding overbought territory. Price hugs the upper Bollinger Band resistance at $0.11, with lower support at $0.1 suggesting volatility exhaustion—expect a quick pullback to that EMA confluence before resuming the grind higher, mirroring patterns seen in recent BTC rallies.